查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1463779

禮賓醫療的全球市場：市場規模和份額分析（按應用（初級保健、兒科、脊椎按摩療法、內科、心臟病學、精神病學）、所有權類型（單一、團體）、最終用戶（成人、兒科）） 、產業需求預測（~2030）

Concierge Medicine Market Size and Share Analysis by Application (Primary Care, Pediatrics, Osteopathy, Internal Medicine, Cardiology, Psychiatry), Ownership (Independent, Group), End User (Adults, Children) - Global Industry Demand Forecast to 2030
出版日期: | 出版商: Prescient & Strategic Intelligence | 英文 310 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

市場概況

全球特約醫療市場規模約171億美元。 然而，到 2030 年，這一數字預計將增加至 276 億美元，2024 年至 2030 年的複合年增長率為 7.3%。

該行業的發展得益於早期疾病診斷知識的增加、老年人口的增加以及個人為實現健康平衡的生活方式而付出的不斷努力。 此外，特約醫療提供的好處包括醫生的薪酬更高和患者的等待時間更短。

關鍵見解

到2023年，初級保健類別將佔據最大的產業份額。 這是由於病患意識的提高、立即就醫和先進的醫療服務。

由於個人化醫療服務和醫療服務提供者的短缺，禮賓醫療保健在高收入人群中越來越受歡迎。

預計兒科在預測期內的複合年增長率最高為 7.8%。 這是因為兒科醫生有更多的時間來治療個別患者，特別是需要針對性診斷和治療的新生兒、嬰幼兒。

到 2023 年，團體類別將以約 60% 的份額主導產業。

預計在預測期內，禮賓醫學的單一管理（從業者）將迅速發展。

在本報告中，我們分析了全球特約醫療市場，包括市場的基本結構、最新情況、主要推動和限制因素以及全球、按地區和主要國家的市場規模前景（以貨幣形式計算，2017 -2030），按用途、所有權類型和最終用戶劃分的詳細趨勢、當前市場競爭狀況以及主要公司概況。

目錄

第1章研究範圍

第2章研究方法

第 3 章執行摘要

第 4 章市場指標

第4章產業展望

  • 市場動態
    • 趨勢
    • 促進因素
    • 抑制因素/挑戰
    • 促進/抑制因子影響分析
  • 新型冠狀病毒感染 (COVID-19) 的影響
  • 波特五力分析

第6章世界市場

  • 摘要
  • 市場收入：依應用分類（2017-2030 年）
  • 市場收入：依所有權類型劃分（2017-2030 年）
  • 市場收入：以最終用戶劃分（2017-2030 年）
  • 市場收入：按地區劃分（2017-2030 年）

第7章北美市場

  • 摘要
  • 市場收入：依應用分類（2017-2030 年）
  • 市場收入：依所有權類型劃分（2017-2030 年）
  • 市場收入：以最終用戶劃分（2017-2030 年）
  • 市場收入：依國家/地區劃分（2017-2030 年）

第8章歐洲市場

第9章亞太市場

第10章拉丁美洲市場

第11章中東及非洲市場

第12章美國市場

  • 摘要
  • 市場收入：依應用分類（2017-2030 年）
  • 市場收入：依所有權結構劃分（2017-2030 年）
  • 市場收入：以最終用戶劃分（2017-2030 年）

第13章加拿大市場

第14章德國市場

第15章法國市場

第16章英國市場

第17章義大利市場

第18章西班牙市場

第19章日本市場

第20章中國市場

第21章印度市場

第22章澳洲市場

第23章韓國市場

第24章巴西市場

第25章墨西哥市場

第26章沙烏地阿拉伯市場

第27章南非市場

第 28 章阿聯酋 (UAE) 市場

第29章競爭態勢

  • 市場參與者及其提供的產品/服務的列表
  • 主要公司的競爭基準
  • 各大公司的產品基準
  • 近期策略發展狀況

第30章公司簡介

  • Campbell Family Medicine
  • Castle Connolly Private Health Partners LLC
  • CONCIERGE CONSULTANTS & CARDIOLOGY
  • MDVIP LLC
  • PartnerMD
  • PENINSULA DOCTOR
  • Priority Physicians Inc.
  • SignatureMD Inc.
  • Specialdocs Consultants LLC

第31章 附錄

簡介目錄
Product Code: 12826

Market Overview

The global concierge medicine market is around USD 17.1 billion. However, this figure is estimated to rise to USD 27.6 billion by 2030, which is equivalent to a 7.3% compound annual growth rate from 2024 to 2030.

This development of the industry can be credited to the increasing knowledge about initial disease diagnosis, the growing elderly populace, and the increasing efforts of individuals to attain a healthy and balanced lifestyle. Moreover, the benefits provided by concierge medicine comprise high recompenses for doctors and reduced waiting times for patients, which make this method common among both.

With the increasing use of telemedicine and tele health, the market picked up. Patients who have availed of concierge medicine services appreciate these technologies as they can schedule consultations with the physician as and when convenient. On the other hand, it replaces traveling that a patient would take to the doctor 's office.

This helps save patients time and money. Telemedicine applications provide high-resolution audio and video teleconferences, which enable easy access for patients to the physician from the comfort of their homes.

In addition to that, providers can manage the number of patients not showing up, since telemedicine could be utilized for this purpose. Thus, the convenience offered by such technologies has a positive impact on patient flow and increases the doctor's revenue.

Key Insights

In 2023, the primary care category grips the largest industry share because of augmented patient awareness, offering instant access to doctors and advanced-quality medicinal services.

For the patients the main advantage of primary care is that they receive longer, more comprehensive consultations, and get used to this setting, with the high patient volumes, to keep pace.

Concierge medicine is gaining popularity among high earners due to personalized healthcare services and the shortage of healthcare providers.

Paediatrics is projected to have the highest CAGR rate of 7.8% during the forecast period because pediatricians will have more time to treat each patient, especially neonates, infants, and toddlers who require targeted diagnosis and treatment.

In 2023, the group category dominates the industry with a share of approximately 60%.

The substantial existence of several top firms in the market offering these services is the major factor propelling the market.

Independent ownership in concierge medication is projected to advance quickly over the forecast period.

Independent practitioners see fewer patients every day in comparison to regular and group ownership models, leading to less workload, better compensation, and job satisfaction.

Rising awareness regarding physical well-being and the accuracy of healthcare boosts industry development.

Well-established healthcare infrastructure and favourable medical reimbursement policies contribute significantly to the region's dominance.

The global increase in the range of diseases of duration such as cancer, hyperglycaemia, and obesity is an issue that facilitates the development of precision medicine solutions.

The presence of a significant elderly population drives demand for immediate medical attention, supporting market growth.

The customization healthcare services, come with convenience and personalized care, thus attracting elderly patients and leading to the broadening of the market.

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by application
    • 1.4.2. Market size breakdown, by ownership
    • 1.4.3. Market size breakdown, by end user
    • 1.4.4. Market size breakdown, by region
    • 1.4.5. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Revenue, by Application (2017-2030)
  • 6.3. Market Revenue, by Ownership (2017-2030)
  • 6.4. Market Revenue, by End User (2017-2030)
  • 6.5. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Revenue, by Application (2017-2030)
  • 7.3. Market Revenue, by Ownership (2017-2030)
  • 7.4. Market Revenue, by End User (2017-2030)
  • 7.5. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Revenue, by Application (2017-2030)
  • 8.3. Market Revenue, by Ownership (2017-2030)
  • 8.4. Market Revenue, by End User (2017-2030)
  • 8.5. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Revenue, by Application (2017-2030)
  • 9.3. Market Revenue, by Ownership (2017-2030)
  • 9.4. Market Revenue, by End User (2017-2030)
  • 9.5. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Revenue, by Application (2017-2030)
  • 10.3. Market Revenue, by Ownership (2017-2030)
  • 10.4. Market Revenue, by End User (2017-2030)
  • 10.5. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Revenue, by Application (2017-2030)
  • 11.3. Market Revenue, by Ownership (2017-2030)
  • 11.4. Market Revenue, by End User (2017-2030)
  • 11.5. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Revenue, by Application (2017-2030)
  • 12.3. Market Revenue, by Ownership (2017-2030)
  • 12.4. Market Revenue, by End User (2017-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Revenue, by Application (2017-2030)
  • 13.3. Market Revenue, by Ownership (2017-2030)
  • 13.4. Market Revenue, by End User (2017-2030)

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Revenue, by Application (2017-2030)
  • 14.3. Market Revenue, by Ownership (2017-2030)
  • 14.4. Market Revenue, by End User (2017-2030)

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Revenue, by Application (2017-2030)
  • 15.3. Market Revenue, by Ownership (2017-2030)
  • 15.4. Market Revenue, by End User (2017-2030)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Revenue, by Application (2017-2030)
  • 16.3. Market Revenue, by Ownership (2017-2030)
  • 16.4. Market Revenue, by End User (2017-2030)

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Revenue, by Application (2017-2030)
  • 17.3. Market Revenue, by Ownership (2017-2030)
  • 17.4. Market Revenue, by End User (2017-2030)

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Revenue, by Application (2017-2030)
  • 18.3. Market Revenue, by Ownership (2017-2030)
  • 18.4. Market Revenue, by End User (2017-2030)

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Revenue, by Application (2017-2030)
  • 19.3. Market Revenue, by Ownership (2017-2030)
  • 19.4. Market Revenue, by End User (2017-2030)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Revenue, by Application (2017-2030)
  • 20.3. Market Revenue, by Ownership (2017-2030)
  • 20.4. Market Revenue, by End User (2017-2030)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Revenue, by Application (2017-2030)
  • 21.3. Market Revenue, by Ownership (2017-2030)
  • 21.4. Market Revenue, by End User (2017-2030)

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Revenue, by Application (2017-2030)
  • 22.3. Market Revenue, by Ownership (2017-2030)
  • 22.4. Market Revenue, by End User (2017-2030)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Revenue, by Application (2017-2030)
  • 23.3. Market Revenue, by Ownership (2017-2030)
  • 23.4. Market Revenue, by End User (2017-2030)

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Revenue, by Application (2017-2030)
  • 24.3. Market Revenue, by Ownership (2017-2030)
  • 24.4. Market Revenue, by End User (2017-2030)

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Revenue, by Application (2017-2030)
  • 25.3. Market Revenue, by Ownership (2017-2030)
  • 25.4. Market Revenue, by End User (2017-2030)

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Revenue, by Application (2017-2030)
  • 26.3. Market Revenue, by Ownership (2017-2030)
  • 26.4. Market Revenue, by End User (2017-2030)

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Revenue, by Application (2017-2030)
  • 27.3. Market Revenue, by Ownership (2017-2030)
  • 27.4. Market Revenue, by End User (2017-2030)

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Revenue, by Application (2017-2030)
  • 28.3. Market Revenue, by Ownership (2017-2030)
  • 28.4. Market Revenue, by End User (2017-2030)

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. Campbell Family Medicine
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. Castle Connolly Private Health Partners LLC
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. CONCIERGE CONSULTANTS & CARDIOLOGY
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. MDVIP LLC
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
  • 30.5. PartnerMD
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. PENINSULA DOCTOR
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. Priority Physicians Inc.
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary
  • 30.8. SignatureMD Inc.
    • 30.8.1. Business overview
    • 30.8.2. Product and service offerings
    • 30.8.3. Key financial summary
  • 30.9. Specialdocs Consultants LLC
    • 30.9.1. Business overview
    • 30.9.2. Product and service offerings
    • 30.9.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports